News

New National Science, Technology, and Innovation Policy on the anvil

The Office of PSA and the Department of Science and Technology have jointly initiated a decentralized, bottom-up, and inclusive process for the formulation of a new national Science Technology and Innovation Policy (STIP 2020).

Jun 03, 2020

By : Team ABLE

Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19

Syngene has indigenously developed an anti-COV-2 IgG ELISA (Enzyme-Linked Immunosorbent Assay) at its research facility in Bengaluru. HiMedia will manufacture the kits at its facility in Mumbai

Jun 03, 2020

By : Team ABLE

Stempeutics India, Novumcella Japan partner for Buerger's Disease drug

Stempeutics plans to commercialize Stempeucel product for the same indication in Japan in partnership with Novumcella.

Jun 03, 2020

By : Team ABLE

FDA clears Cellenkos’ trial of cryopreserved cord blood-derived T-Regulatory Cells for COVID-19 treatment

CK0802 is an off-the-shelf, allogeneic T-regulatory cell product that is cryopreserved, shipped to the clinical site and infused at the patient's bedside

Jun 02, 2020

By : Team ABLE

IIT researchers to re-purpose approved drugs from DrugBank database for treating COVID-19 by targeting SARS-CoV-2 main protease

Taking advantage of available crystal structure of the SARS-CoV-2 main protease, a structure-based inhibitor design will be done by the researchers from the available FDA approved drugs compounds in the DrugBank database.

Jun 02, 2020

By : Team ABLE